Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_360Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHLA-204000 cells per wellNAMTS cell survival assay0.0001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_361Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHP-1344000 cells per wellNAMTS cell survival assay0.0001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_362Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-AS4000 cells per wellNAMTS cell survival assay0.0001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_363Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-BE(2)4000 cells per wellNAMTS cell survival assay0.0001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_364Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHLA-204000 cells per wellNAMTS cell survival assay0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_365Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHP-1344000 cells per wellNAMTS cell survival assay0.01 MOI18% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_366Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-AS4000 cells per wellNAMTS cell survival assay0.01 MOI76% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_367Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-BE(2)4000 cells per wellNAMTS cell survival assay0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_368Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHLA-204000 cells per wellNAMTS cell survival assay0.1 MOI98% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_369Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHP-1344000 cells per wellNAMTS cell survival assay0.1 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_370Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-AS4000 cells per wellNAMTS cell survival assay0.1 MOI26% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_371Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-BE(2)4000 cells per wellNAMTS cell survival assay0.1 MOI58% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_372Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHLA-204000 cells per wellNAMTS cell survival assay1 MOI72% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_373Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineCHP-1344000 cells per wellNAMTS cell survival assay1 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_374Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-AS4000 cells per wellNAMTS cell survival assay1 MOI15% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_375Herpes simplex virusSeprehvir (HSV1716)DNAHerpesviridaeΔγ134.5 attenuated virus mutantYesNoNoATCC or from the Pediatric Preclinical Testing Program (PPTP)Human neuroblastoma cell lineSK-N-BE(2)4000 cells per wellNAMTS cell survival assay1 MOI18% cancer cell viabilityNoNoNA No responseNANANANA26583803
OV_927Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_928Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_929Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_930Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 virus particle/ cellAll cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_931Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_932Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 virus particle/ cell60% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_933Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 virus particle/ cell60% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_934Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 virus particle/ cellAll cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_935Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_936Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_937Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_938Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_939Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_940Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_941Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_942Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10000 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_943Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_944Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_945Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_946Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_947Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_948Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_949Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA1000 virus particle/ cell85% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_950Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_951Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_952Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_953Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_954Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_955Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_956Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA100 virus particle/ cell75% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_957Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA1000 virus particle/ cell75% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_958Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_959Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_960Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_961Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 virus particle/ cell60% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_962Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 virus particle/ cell20% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_963Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 virus particle/cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_964Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_965Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_966Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_967Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_968Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_969Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_970Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_971Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_972Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA100 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_973Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_974Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10000 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_975Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_976Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_977Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 virus particle/ cell50% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_978Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 virus particle/ cell20% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_979Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_980Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_981Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA1000 virus particle/ cell85% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_982Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_983Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10 virus particle/cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_984Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA100 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_985Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA1000 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_986Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10000 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_987Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_988Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA100 virus particle/ cell75% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_989Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA1000 virus particle/ cell75% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_990Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_991Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell90% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_992Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell90% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_993Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell80% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_994Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell60% cell kills after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_995Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell90% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_996Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell50% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_997Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell20% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_998Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell100% cell kills after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_999Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell60% cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1000Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell100% cell kills after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1001Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell100% cell kills after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1002Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell100% cell kills after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1003Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell10% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1004Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell100% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1005Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell100% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1006Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell100% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1007Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1008Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1009Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1010Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 pfu/cell90% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577